Last CNY15.42 CNY
Change Today -0.48 / -3.02%
Volume 33.0M
600518 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Open
CNY15.82
Previous Close
CNY15.90
Day High
CNY15.91
Day Low
CNY15.38
52 Week High
11/5/13 - CNY20.88
52 Week Low
07/18/14 - CNY13.80
Market Cap
33.9B
Average Volume 10 Days
39.0M
EPS TTM
CNY0.89
Shares Outstanding
2.2B
EX-Date
07/22/14
P/E TM
17.3x
Dividend
CNY0.26
Dividend Yield
1.69%
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices primarily in China. The company's principal products include Chinese medicines, such as American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. Its products also comprise chemical drugs consisting of clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol and pseudoephedrine hydrochloride tablets, and others. In addition, the company is involved in the wholesale and retail of other medical materials, such as bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Puning, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Oct 15, 2014

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Oct 15, 2014. Agenda: To discuss and approve the 'proposal of meeting conditions for corporate bonds issuance; to consider the 'proposal of publicly issuing corporate bonds; and to consider the proposal of convening 3rd special shareholders' meeting of 2014.

Kangmei Pharmaceutical Co., Ltd. to Report First Half, 2014 Results on Aug 26, 2014

Kangmei Pharmaceutical Co., Ltd. announced that they will report first half, 2014 results on Aug 26, 2014

Kangmei Pharmaceutical Co., Ltd. Announces Earnings Results for the First Half of 2014

Kangmei Pharmaceutical Co., Ltd. announced earnings results for the first half of 2014. For the period, the company reported basic earnings per share of CNY 0.467 and weighted average return on net assets of 8.19%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY15.42 CNY -0.48

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies
 

Industry Analysis

600518

Industry Average

Valuation 600518 Industry Range
Price/Earnings 17.5x
Price/Sales 2.3x
Price/Book 2.8x
Price/Cash Flow 17.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit www.kangmei.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.